North America Platelet Aggregation Devices Market hit to reach USD 150.79 Million by 2021

The North America Platelet Aggregation Devices Market was worth USD 60.8 million in 2016 and is estimated to be growing at a CAGR of 19.92%, to reach USD 150.79 million by 2021. Platelets are a component of blood and are responsible for the formation of blood clots in the body. Platelets reach the site of the injury after receiving chemical signals and from clots at the damaged area with the help of collagen and other molecules.

Browse Market data tables and in-depth TOC of the North America Platelet Aggregation Devices Market to 2021 @

The assembling of platelets in the blood is called platelet aggregation. Aggregation is followed by a series of events to result in clot formation. The tests which are used to assess the extent to which the platelets are assembled together are called platelet aggregation tests. Platelet disorders occur in blood resulting in increase or decrease in the number of platelets. Platelet aggregation devices such as aggregators are available to control the formation of clots in the body.

Increasing number of technological advancements in aggregation devices, growing number of cardiovascular surgeries and increasing adoption of platelet therapy are the major factors driving the market for platelet aggregation devices market. Also, increasing number of collaborations of industries and research institutes are also driving the market growth. Unfavorable healthcare reforms and lack of skilled professionals is restraining the market growth.

Free sample of the report is available @

The North America market for platelet aggregation devices is segmented by product, applications, end user and by region. Based on product, the market is segmented into systems, reagents and consumables and accessories. Platelet aggregation systems hold the largest market share due to the increasing automation of aggregation testing procedures. Based on application, the market is segmented into clinical applications and research applications. Clinical applications are again segmented into cardiovascular applications, orthopedic applications and other clinical applications. Clinical applications segment holds the largest market share due to the increased adoption of aggregator devices by healthcare professionals. Based on end user, the market is segmented into standalone hospitals, diagnostic laboratories, research and academic institutes and other end users. Standalone hospitals are expected to hold the largest market share in end users segment due to the increase in platelet disorders and increasing use of platelet therapy for cancer patients.

Based on region, the North America market is segmented into USA and Canada. USA dominates the market in this region due to the rising number of surgical procedures and bleeding disorders.

Avail discount @

Key players in the platelet aggregation devices market are Accriva Diagnostics, Helena Laboratories Corporation, BioData Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Sentinel CH. S.p.A., Tem Group and Aggredyne, Inc.

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.


Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Visit MarketDataForecast Blog @

View latest Press Releases of MDF @

%d bloggers like this: